tiprankstipranks
Trending News
More News >
Innate Pharma (IPHA)
NASDAQ:IPHA
Advertisement

Innate Pharma (IPHA) Similar Stocks

Compare
122 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma
$2.03
$189.76M
-1.93%
1 Buy
3 Hold
0 Sell
Hold
SELLAS Life Sciences Group
$1.91
$199.54M
54.03%
1 Buy
0 Hold
0 Sell
Moderate Buy
Sangamo Biosciences
$0.67
$222.93M
-20.00%
3 Buy
1 Hold
0 Sell
Strong Buy
Genfit SA
$4.25
$222.39M
109.67
-29.87%
2 Buy
0 Hold
0 Sell
Moderate Buy
Elicio Therapeutics
$10.58
$180.54M
121.34%
2 Buy
0 Hold
0 Sell
Moderate Buy
Vor Biopharma
$31.23
$217.00M
133.06%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IPHA
Innate Pharma
2.03
<0.01
0.50%
SLS
SELLAS Life Sciences Group
1.91
0.66
52.80%
SGMO
Sangamo Biosciences
0.67
-0.26
-27.96%
GNFT
Genfit SA
4.25
-1.86
-30.44%
ELTX
Elicio Therapeutics
10.58
5.97
129.50%
VOR
Vor Biopharma
31.23
17.94
134.99%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis